Venture capital firm based in Cambridge, UK
Edinburgh based Trogenix raises £70m led by IQ Capital with 4BIO Capital. Trogenix's Odysseus platform combines targeted cancer cell killing and immune stimulation to deliver precise, potentially curative therapies. Read more
Biotech firm Enhanced Genomics raises £13.9m led by BGF with Parkwalk. Enhanced Genomics's 3D multi-omics platform combines three-dimensional mapping and cell-type specificity to identify drug targets. Read more
Qureight secures $8.5M in funding to revolutionize clinical trials with AI technology, poised for success in the booming $92bn global market. Read more
| Biotech | 100.0% |